Thursday, January 05, 2017 8:57:43 AM
SYN - .8818 Pre-market now at .99/.999.
Synthetic Biologics Meets Primary Endpoint In Study Of C. Diff Treatment -- Shares Up More Than 12%
Synthetic Biologics Meets Primary Endpoint In Study Of C. Diff Treatment -- Shares Up More Than 12%
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
